Home › Free Stock Grades › PGEN
Precigen, Inc. (PGEN) Stock Grade
PGEN · Healthcare
A-
Market Cap
$1.3B
P/E Ratio
—
Revenue Growth (YoY)
+146.7%
Net Margin
-2588.2%
Return on Equity
—
Dividend Yield
None
About Precigen, Inc.'s fundamentals
Precigen reported exceptional revenue growth of 146.7% year-over-year, demonstrating strong commercial traction in its business operations. However, the company posted a substantial net loss in its latest annual statement, resulting in a net margin of -2588.2%, indicating that expenses significantly exceeded revenues. With a market capitalization of $1.3 billion and no dividend payments, the company is in a pre-profitability stage typical of biotechnology firms investing heavily in research and development or market expansion.